Lipitor Cuts Merkley From Review

Be among trailblazing marketing pros at Brandweek this September 23–26 in Phoenix, Arizona. Experience incredible networking, insightful sessions and a boost of inspiration at ADWEEK’s ultimate brand event. Register by May 13 to save 35%.

NEW YORK Omnicom Group’s Merkley + Partners, the creative incumbent on Pfizer’s Lipitor, has been eliminated from the client’s review, leaving three New York shops vying for the estimated $60-80 million account, sources said.

The remaining shops are WPP Group’s JWT, Publicis Groupe’s The Kaplan Thaler Group and mcgarrybowen, an independent, according to sources. The agencies either declined comment or did not return calls.

Merkley, which has handled creative duties on the brand since December 2000, did not return calls.



AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in